About Us- Biogenomics

About Us

Focused on Diabetes &
Cancer Biopharmaceuticals

Founded by technocrats with MNC experience. Headquarter near Mumbai, India.
200+ total employees including 70+ scientists.

Fully equipped, Department of Scientific & Industrial Research (DSIR) approved, Good Laboratory Practices (GLP) compliant research and development centre near Mumbai, India, (ISO 9001:2015, ISO:140001, ISO:18001 certified).
State of the art Good Manufacturing Practices (GMP) manufacturing and fill + finish facilities in Pondicherry, India.

Vision

Increasing access to
Life-Saving Biopharmaceuticals
through adaptive innovations

Mission

To develop innovative products,
technologies and business practices.
To deliver high quality products
through a safe and compliant environment
with advanced infrastructure.
To develop enriching relationships with our
customers, employees and business partners.

Board of Directors

Mr. R. M. Parakh, Chairman & Managing Director

Mr. R. M. Parakh,
Chairman & Managing Director

Mr. Parakh is a highly experienced and respected business professional and is considered a visionary amongst his peers
Over the last more than three decades, he has successfully displayed the best of his dynamism and visionary leadership in one of the largest trading houses in the Middle East, with an annual turnover of US$ 5 billion
Mr. Parakh has played a key role in growth of India-Oman bilateralism.
He is also a supporter of several humanitarian causes

Dr. M. Barwani, Director

Dr. Barwani is the Founder and Chairman of the MB Holding Group, a holding company with diverse interests
Dr. Barwani is on the Board of several joint stock companies in Oman including Transgulf Investment Holding Company (Chairman), Al Madina Gulf Insurance Co. (Chairman), Oman Aviation Services Co. Dr. Barwani was on the Board of Directors of the National Bank of Oman (1997-2005), Taageer Investment & Leasing Co. (2001-2005) and Shell Oman Marketing Co. SAOG (2001-2006)

Dr. Sulaiman Al Harthy, Director

Eminent, senior and highly respected Omani citizen
Senior position in Oman Government
Medical Doctor
Several Directorships in leading Omani and global companies

Mr. Sushil Srivastava, Director

Mr. Srivastava is the Chief Financial Officer of MB Holding Group, which he joined in 2001
He has over 23 years of experience in corporate finance, M&A, project finance and structuring
He worked with premier financial institutions and merchant bankers in India for eight years playing key roles in project financing, financial due diligence, economic modelling, advisory services and initial public offerings

Sanjay Sonar (Ph.D.), Co-Founder, Director

Sanjay Sonar (Ph.D.),
Co-Founder, Director

Over 30 years of experience in downstream and protein engineering
Ph.D. from Indian Institute of Technology, Bombay; Post-doctoral work at Boston University and MIT, Cambridge, (USA)
Worked in a close collaboration with Nobel Laureate Har Gobind Khorana at MIT for 6 years
Holds over 100 patents

Dr. Archana Krishnan, Director

Over 20 years of experience in molecular biology, strain development and upstream process
Ph.D. from the Center of DNA Fingerprinting and Manipal University
Gold medalist at University of Baroda
Holds over 27 patents

Abhishek Deshpande, CFO

17 years of national and international management experience
Responsible for management and administration of business operations
Chartered Accountant with management studies

Careers

Contact Us

About Us

Focused on Diabetes &
Cancer Biopharmaceuticals

Founded by technocrats with MNC experience. Headquarter near Mumbai, India.
200+ total employees including 70+ scientists.

Vision

Mission